Hodgkin's disease.

[1]  E. Jaffe,et al.  Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Jaffe,et al.  Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Hancock,et al.  Correction: Deaths after Treatment of Hodgkin Disease , 1991 .

[4]  J. Strauchen,et al.  Human immunodeficiency virus‐associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells , 1991 .

[5]  H. Tilly,et al.  Cytogenetic studies in untreated Hodgkin's disease. , 1991, Blood.

[6]  S. Hamilton-Dutoit,et al.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.

[7]  E. Jaffe,et al.  Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Yahalom,et al.  Autologous bone marrow transplantation for refractory or relapsed Hodgkin's disease: the Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  N. Mueller.  An epidemiologist's view of the new molecular biology findings in Hodgkin's disease. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  H. Stein,et al.  The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  A. Santoro,et al.  Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  V. Diehl,et al.  Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Longo Dl.  The use of chemotherapy in the treatment of Hodgkin's disease. , 1990 .

[14]  P. Banks.  The pathology of Hodgkin's disease. , 1990, Seminars in oncology.

[15]  T. Miller,et al.  Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A southwest oncology group study , 1990, Cancer.

[16]  R. Hoppe.  Radiation therapy in the management of Hodgkin's disease. , 1990, Seminars in oncology.

[17]  D. Linch,et al.  Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation. , 1990, BMJ.

[18]  L. Prosnitz,et al.  Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas , 1990, Cancer.

[19]  J. Fermanian,et al.  Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. Clarkson,et al.  Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Gingrich,et al.  BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma. , 1990, Blood.

[22]  H. Stein,et al.  Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. , 1990 .

[23]  R. Holle,et al.  Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Rahul Gupta,et al.  Testicular dysfunction after cyclophosphamide‐vincristine‐procarbazine‐prednisolone chemotherapy for advanced hodgkin's disease a long‐term follow‐up study , 1990 .

[25]  S. Hsu.  The never-ending controversies in Hodgkin's disease. , 1990, Blood.

[26]  K. Sullivan,et al.  Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  T. Haynie,et al.  Role of the gallium scan in Hodgkin's disease , 1990 .

[28]  S. Piantadosi,et al.  High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  N. Day,et al.  Leukemia following Hodgkin's disease. , 1990, The New England journal of medicine.

[30]  A. Santoro,et al.  Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  C. Haanen,et al.  Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  I. Magrath,et al.  High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M Tubiana,et al.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  D. Weisenburger,et al.  High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. , 1989, Blood.

[35]  A. Hart,et al.  Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  J. Fay,et al.  Allogeneic marrow transplantation for refractory Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  G. Papa,et al.  MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  S. Steinberg,et al.  Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Fay,et al.  Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation. , 1989, Blood.

[40]  N. Harris,et al.  Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. , 1989, The New England journal of medicine.

[41]  J. Diebold,et al.  Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie. , 1989, European journal of cancer & clinical oncology.

[42]  J. Armitage,et al.  Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  T. Ahmed,et al.  High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. , 1989, Leukemia.

[44]  B. Efron,et al.  Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  M Tubiana,et al.  Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. , 1989, Blood.

[46]  J. Gribben,et al.  Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. , 1989, Blood.

[47]  P. Smith,et al.  Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  S. Hancock,et al.  Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  M. Maschio,et al.  Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. , 1988, Journal of the National Cancer Institute.

[50]  C. Coleman,et al.  Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  K. Hopper,et al.  Hodgkin disease: clinical utility of CT in initial staging and treatment. , 1988, Radiology.

[52]  P. Mazza,et al.  High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  A. Hagenbeek,et al.  Subsequent development of acute non‐lymphocytic leukemia in patients treated for Hodgkin's disease , 1988, International journal of cancer.

[54]  J. Armitage,et al.  ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease. , 1988, American journal of clinical oncology.

[55]  S. Hancock,et al.  Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. , 1988, Annals of internal medicine.

[56]  D Crowther,et al.  The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  L. Specht,et al.  Hodgkin's disease stages I and II with infradiaphragmatic presentation: A rare and prognostically unfavourable combination * , 1988, European journal of haematology.

[58]  J. Connors,et al.  An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. , 1988, Seminars in hematology.

[59]  J. Bertino,et al.  Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  M. Tucker,et al.  Risk of second cancers after treatment for Hodgkin's disease. , 1988, The New England journal of medicine.

[61]  Umberto Vitolo,et al.  Predictive value of the early response to chemotherapy in high‐risk stages II and III Hodgkin's disease , 1987, Cancer.

[62]  C. Haanen,et al.  Major complications and causes of death in patients treated for Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  A. Hart,et al.  SPLENECTOMY IN HODGKIN'S DISEASE AND SECOND LEUKAEMIAS , 1987, The Lancet.

[64]  M. Raffeld,et al.  Rearranged antigen receptor genes in Hodgkin's disease [published erratum appears in Blood 1987 Sep;70(3):893] , 1987 .

[65]  H. Hansen,et al.  RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE Relation to Age, Cumulative Dose of Alkylating Agents, and Time from Chemotherapy , 1987, The Lancet.

[66]  R. Hoppe,et al.  Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  D. Rosenthal,et al.  Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  S. Rosenberg,et al.  Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  W. Velasquez,et al.  MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  P. Duffey,et al.  Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. , 1987, The New England journal of medicine.

[71]  C. Willett,et al.  Results of treatment of stage IA and IIA Hodgkin's disease , 1987, Cancer.

[72]  R. Gralla,et al.  Semen cryopreservation and artificial insemination for Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  C. Willett,et al.  Results of treatment of stage 3A Hodgkin's disease , 1987, Cancer.

[74]  A. Bartolucci,et al.  Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease: A southeastern cancer study group trial , 1986, Cancer.

[75]  P. Mauch,et al.  Hodgkin's disease presenting below the diaphragm: a review. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  E. Jaffe,et al.  Twenty years of MOPP therapy for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  T. Pajak,et al.  Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B. , 1986, Journal of Clinical Oncology.

[78]  A. Santoro,et al.  Second acute leukemia and other malignancies following treatment for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  D. Longo,et al.  Concomitant illness in patients treated for Hodgkin's disease. , 1986, Cancer treatment reviews.

[80]  A. Santoro,et al.  Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. , 1986, Annals of internal medicine.

[81]  P. Hervé,et al.  High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease. , 1986, British Journal of Cancer.

[82]  P. Rubin,et al.  Hodgkin's disease. IIB or not to be--using irradiation alone or in combination with chemotherapy? That is the question! , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  S. Rosenberg,et al.  Stage IIB Hodgkin's disease: the Stanford experience. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  A. Santoro,et al.  CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. , 1986, Seminars in oncology.

[85]  E. Jaffe,et al.  The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  P. Rubin,et al.  Hodgkin's disease: is there a price for successful treatment? A 25-year experience. , 1986, International journal of radiation oncology, biology, physics.

[87]  G. Morgan,et al.  Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. , 1985, International journal of radiation oncology, biology, physics.

[88]  H. Deeg,et al.  Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  D. Rosenthal,et al.  Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  D. Ferguson,et al.  Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  D. Rosenthal,et al.  The significance of the residual mediastinal mass in treated Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  A. Santoro,et al.  Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. , 1985, European journal of cancer & clinical oncology.

[93]  D. Rosenthal,et al.  Reduction of fatal complications from combined modality therapy in Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  D. Johnston,et al.  Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin , 1985, Cancer.

[95]  J R Krause,et al.  Secondary non‐hematopoietic cancers arising following treatment of hematopoietic disorders , 1985, Cancer.

[96]  F. Greco,et al.  Lung cancer in Hodgkin's disease: association with previous radiotherapy. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  L. Prosnitz,et al.  Treatment selection for stage IIIA Hodgkin's disease patients. , 1984, International journal of radiation oncology, biology, physics.

[98]  P. O'dwyer,et al.  Treatment of early stage Hodgkin’s disease: A randomized trial of radiotherapy plus chemotherapy versus chemotherapy alone , 1985 .

[99]  A. Santoro,et al.  Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy. , 1985, Cancer surveys.

[100]  M. Tubiana,et al.  A multivariate analysis of prognostic factors in early stage Hodgkin's disease. , 1985, International journal of radiation oncology, biology, physics.

[101]  L. F. Fajardo,et al.  Radiation-induced heart disease: an update. , 1984 .

[102]  S. Rosenberg,et al.  Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. , 1984, Annals of internal medicine.

[103]  P. Mazza,et al.  Acute leukaemia in patients treated for Hodgkin's disease , 1984, British journal of haematology.

[104]  N. Gutensohn,et al.  A population‐based case‐control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings , 1984, International journal of cancer.

[105]  D. Deakin,et al.  A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  R. Castellino,et al.  Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease. , 1984, AJR. American journal of roentgenology.

[107]  R. Makuch,et al.  Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  E. Henderson,et al.  Large mediastinal mass in Hodgkin's disease: Results of two treatment modalities , 1984, American journal of clinical oncology.

[109]  R. Mertelsmann,et al.  Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations. , 1984, American Journal of Medicine.

[110]  J. Earle,et al.  Prognostic significance of mediastinal mass in adult Hodgkin's disease , 1984, Cancer.

[111]  A. Bartolucci,et al.  Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease , 1983, Cancer.

[112]  G E Hanks,et al.  Patterns of care study: Hodgkin's disease relapse rates and adequacy of portals , 1983, Cancer.

[113]  T. Lister,et al.  The treatment of stage IIIA Hodgkin's disease. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  M. Chou,et al.  Severe pneumococcal infection in patients with neoplastic disease , 1983, Cancer.

[115]  W. H. Bond,et al.  Treatment of MOPP‐refractory Hodgkin‐s disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine , 1983, Cancer.

[116]  S. Rosenberg,et al.  A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[117]  K. Ho,et al.  Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease: An immunologic rebound phenomenon? , 1983, Cancer.

[118]  S. Rosenberg,et al.  Single agent palliative chemotherapy for end‐stage Hodgkin's disease , 1982, Cancer.

[119]  S. Rosenberg,et al.  The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. , 1982, Blood.

[120]  A. Santoro,et al.  Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. , 1982, Blood.

[121]  A. Santoro,et al.  Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. , 1982, Annals of internal medicine.

[122]  C. Bloomfield,et al.  Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative radiotherapy , 1980, Cancer.

[123]  V. Devita,et al.  Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. , 1980, Annals of internal medicine.

[124]  D. Rosenthal,et al.  Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. , 1980, Annals of internal medicine.

[125]  P. Wiernik,et al.  Radiation-Related Thyroid Dysfunction: Implications for the Treatment of Hodgkin's Disease , 1980, Annals of Internal Medicine.

[126]  R. Fisher,et al.  Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. , 1979, Annals of internal medicine.

[127]  S. Rosenberg,et al.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. , 1979, The New England journal of medicine.

[128]  P. Mauch,et al.  The significance of mediastinal involvement in early stage Hodgkin's disease , 1978, Cancer.

[129]  S M Hubbard,et al.  Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy , 1978, Cancer.

[130]  D. Rosenthal,et al.  The place of radiation therapy in the treatment of Hodgkin's disease , 1978, Cancer.

[131]  T. Lister,et al.  MVPP chemotherapy regimen for advanced Hodgkin's disease , 1978, British medical journal.

[132]  M. D. Shanklin,et al.  Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. , 1975, British medical journal.

[133]  G. Bonadonna,et al.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.

[134]  R. Castellino,et al.  Latent radiation injury of lungs or heart activated by steroid withdrawal. , 1974, Annals of internal medicine.

[135]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.